In a preliminary observational study, our research group found a significant association between elevated OPG levels and the presence of increased all-cause mortality in a cohort of patients with CKD stages 3–5 over a 3-year follow-up period13. This evidence concerns the gene TNFRSF11B and chronic kidney disease.